Life Sciences Voice Top Five Newsletter

May 5, 2023

Regeneron Shifts Strategy for Lymphoma Bispecific, Focuses on Follicular Lymphoma

February 28, 2025

Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology

April 4, 2022

Must Read

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

April 30, 2026

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

April 30, 2026

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

April 30, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

TIGIT dream fails in phase three, Gilead breaks off its relationship with Arcus

Merck and Eisai Three-Drug Combination Therapy Fails to Meet Survival Endpoints in Phase 3 RCC Trial

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Clinical

Phase 3 of Neurocrine’s Ingrezza cerebral palsy trial unsuccessful

Editor Picks

Life Sciences Voice Top Five Newsletter

Regeneron Shifts Strategy for Lymphoma Bispecific, Focuses on Follicular Lymphoma

Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology

Must Read

Revolution Challenges Erasca’s ERAS-0015 Over Patent and Data Comparison Claims

Lilly and Profluent Sign Up to $2.25 Billion Collaboration to Develop AI-Designed Genetic Medicines

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Hot Topics

About Us

Follow Us